Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.

Chu HS, Hu FR, Yang CM, Yeh PT, Chen YM, Hou YC, Chen WL.

Cornea. 2011 Jan;30(1):60-6. doi: 10.1097/ICO.0b013e3181e458c5.

PMID:
20847676
2.

Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab.

Chu HS, Chen TC, Hu FR, Chen WL.

Cornea. 2013 Nov;32(11):1446-53. doi: 10.1097/ICO.0b013e31825ec407.

PMID:
24055900
3.

Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.

Oh JY, Kim MK, Wee WR.

Cornea. 2009 Oct;28(9):1070-3. doi: 10.1097/ICO.0b013e31819839f9.

PMID:
19724199
4.

Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.

Qian CX, Bahar I, Levinger E, Rootman D.

Cornea. 2008 Oct;27(9):1090-2. doi: 10.1097/ICO.0b013e31817c41e3.

PMID:
18812781
5.

Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.

You IC, Kang IS, Lee SH, Yoon KC.

Acta Ophthalmol. 2009 Sep;87(6):653-8. doi: 10.1111/j.1755-3768.2008.01399.x.

6.

Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.

Koenig Y, Bock F, Kruse FE, Stock K, Cursiefen C.

Cornea. 2012 Aug;31(8):887-92. doi: 10.1097/ICO.0b013e31823f8f7a.

PMID:
22362005
7.

Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.

Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1659-65. doi: 10.1167/iovs.08-1997.

PMID:
18997093
8.

Subconjunctival bevacizumab injection for corneal neovascularization.

Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A.

Cornea. 2008 Feb;27(2):142-7. doi: 10.1097/ICO.0b013e318159019f.

PMID:
18216566
9.

The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency.

Lin CT, Hu FR, Kuo KT, Chen YM, Chu HS, Lin YH, Chen WL.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6277-85. doi: 10.1167/iovs.09-4571.

PMID:
20435600
10.

[Subconjunctival bevacizumab for corneal neovascularization].

Gueudry J, Richez F, Tougeron-Brousseau B, Genevois O, Muraine M.

J Fr Ophtalmol. 2010 Nov;33(9):630-6. doi: 10.1016/j.jfo.2010.07.007. French.

11.

Subconjunctival bevacizumab for corneal neovascularization.

Zaki AA, Farid SF.

Acta Ophthalmol. 2010 Dec;88(8):868-71. doi: 10.1111/j.1755-3768.2009.01585.x.

12.

Subconjunctival bevacizumab for corneal neovascularization.

Doctor PP, Bhat PV, Foster CS.

Cornea. 2008 Oct;27(9):992-5. doi: 10.1097/ICO.0b013e31817786ad.

PMID:
18812760
13.

Subconjunctival bevacizumab for corneal neovascularization.

Erdurmus M, Totan Y.

Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1577-9.

PMID:
17458556
14.

Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.

Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A.

Curr Eye Res. 2008 Jan;33(1):23-8. doi: 10.1080/02713680701799101.

PMID:
18214740
15.

Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).

Kim TI, Kim SW, Kim S, Kim T, Kim EK.

Cornea. 2008 Apr;27(3):349-52. doi: 10.1097/ICO.0b013e31815cf67d.

PMID:
18362666
16.

Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.

Yeung SN, Lichtinger A, Kim P, Amiran MD, Slomovic AR.

Cornea. 2011 Oct;30(10):1110-4. doi: 10.1097/ICO.0b013e31821379aa.

PMID:
21673570
17.

Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.

You IC, Im SK, Lee SH, Yoon KC.

Cornea. 2011 Jan;30(1):30-3. doi: 10.1097/ICO.0b013e3181dc81a0.

PMID:
20861729
18.

The effect of topical bevacizumab on corneal neovascularization.

Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI.

Ophthalmology. 2008 Jun;115(6):e33-8. doi: 10.1016/j.ophtha.2008.02.013.

PMID:
18439681
19.

Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.

Foroutan A, Fariba B, Pejman B, Mahmoud J, Khalil GF, Arash EA, Foroutan P.

Cornea. 2010 Nov;29(11):1268-72. doi: 10.1097/ICO.0b013e3181d92834.

PMID:
20802316
20.

Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.

Benayoun Y, Adenis JP, Casse G, Forte R, Robert PY.

Cornea. 2012 Aug;31(8):937-44. doi: 10.1097/ICO.0b013e31823f8d71.

PMID:
22357391
Items per page

Supplemental Content

Support Center